{"transactions":[{"id":3689145,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160920,"kind":"person","name":"Gottlieb Daniel Philip","position":1,"cik":"0001619811","reported_name":"Gottlieb Daniel Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Corporate Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T21:20:55.000Z","date":"2019-01-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":60000,"derivative":{"exercise_price":2.64,"expiration_date":"2029-01-17","underlying":"Common Stock, $0.001 par value","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001171843-19-000440","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319000440/ownership.xml","form_type":"4"}},{"id":4095795,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160920,"kind":"person","name":"Gottlieb Daniel Philip","position":1,"cik":"0001619811","reported_name":"Gottlieb Daniel Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Corporate Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T22:17:11.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":110000,"derivative":{"exercise_price":2.85,"expiration_date":"2028-01-16","underlying":"Common Stock, $0.001 par value","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001171843-18-000442","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184318000442/formfour.xml","form_type":"4"}},{"id":4480352,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":160920,"kind":"person","name":"Gottlieb Daniel Philip","position":1,"cik":"0001619811","reported_name":"Gottlieb Daniel Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Corporate Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-26T13:01:14.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":29215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 24, 2017 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":29215,"derivative":{"exercise_price":2.05,"expiration_date":"2027-01-23","underlying":"Common Stock, $0.001 par value","underlying_shares":29215},"source":{"system":"sec-edgar","filing":"0001171843-17-000453","document":"f4_gottlieb012617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317000453/f4_gottlieb012617.xml","form_type":"4"}}]}